Results

eNauka >  Rezultati >  Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Naziv: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
Autori: Isaacson, Stuart H; Ballard, Clive G; Kreitzman, David L; Coate, Bruce; Norton, James C; Fernandez, Hubert H; Ilic, Tihomir V ; Azulay, Jean-Philippe; Ferreira, Joaquim J; Abler, Victor;
Stankovic, Srdjan;
Godina: 2021
Publikacija: PARKINSONISM & RELATED DISORDERS
ISSN: 1353-8020 Parkinsonism and Related Disorders Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 87 str. 25-31
DOI: 10.1016/j.parkreldis.2021.04.012
WoS-ID: 000668350200007
Scopus-ID: 2-s2.0-85105295488
URI: https://enauka.gov.rs/handle/123456789/805523
Projekat: ACADIA Pharmaceuticals Inc., San Diego, California
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

21
SCOPUSTM
4
OpenCitations
17
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.